Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Executes ex-SFDA Head

publication date: Jul 11, 2007
Accepted Bribes to Approve Drugs Just six weeks after receiving a death sentence, convicted one-time head of the Chinese FDA, Zheng Xiaoyu, exhausted his appeal of the sentence and was executed soon afterwards. Zheng was convicted of accepted bribes totaling $850,000 to approve drugs during his tenure as the first head of the SFDA. Some 137 of the drug approved under Zheng's watch did not follow the stipulated regulations; six were determined to be fakes; and one, an antibiotic, caused 10 deaths. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital